Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-24 @ 10:53 PM
NCT ID:
NCT03676569
Eligibility Criteria:
Inclusion Criteria:
* Drug-resistant epilepsy confirmed in anamnesis and diagnostic tests (EEG, MR)
* Children between 3 and 18 years old
* Presence of antineuronal antibody in serum or CSF
* Rasmussen encephalitis (proven cellular immunity pathogenesis)
* Probable autoimmune pathogenesis (autoimmune diseases in family, febrile infection associated refractory epilepsy)
* Willing and able to provide written informed consent (patient or legal guardian)
Exclusion Criteria:
* Refractory epilepsy with proven genetic or metabolic ethiology
* Neoplastic disease
* Active inflammatory process at the time of recruitment
* Coagulation disorder
* Status epilepticus
* Participation in another clinical trial
* Lack of willingness and ability to provide written informed consent
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03676569
Study Brief:
Protocol Section:
NCT03676569